Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-021456

Options or other derivatives

  • SVP, GENERAL COUNSEL acquired 76,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sandercock Colin · SVP, GENERAL COUNSEL

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-09 Grant or award : show line 1 in the form Stock Option (right to buy) +60,000 60,000 D
2022-03-25 Grant or award : show line 2 in the form Stock Option (right to buy) +16,667 16,667 D
Loading xslF345X03/doc4.xml…